Oncology Institute (TOIIW) Operating Expenses (2020 - 2026)

Oncology Institute (TOIIW) has reported Operating Expenses for 7 consecutive years, with $154.0 million the latest figure, recorded in Q1 2026.

• Operating Expenses for Q1 2026 came in at $154.0 million, up 34.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $578.4 million (up 27.07% YoY), and the FY2025 annual result was $538.8 million, up 18.8% from the prior year.
• Operating Expenses was $154.0 million for Q1 2026 at Oncology Institute, up from $148.9 million in the prior quarter.
• Over five years, Operating Expenses peaked at $154.0 million in Q1 2026 and troughed at $73.6 million in Q1 2022.
• Average Operating Expenses over 5 years is $110.7 million, with a median of $112.2 million recorded in 2024.
• Year-over-year, Operating Expenses surged 56.29% in 2022 and increased 1.49% in 2025.
• Over 5 years, Operating Expenses stood at $96.5 million in 2022, then climbed by 4.74% to $101.1 million in 2023, then gained by 11.0% to $112.2 million in 2024, then surged by 32.68% to $148.9 million in 2025, then rose by 3.42% to $154.0 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $154.0 million in Q1 2026, $148.9 million in Q4 2025, and $144.6 million in Q3 2025.